secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0001214659-24-017141
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro enters ATM offering for up to $6.5M in common stock
------------------------------------------------------------------

- Entered ATM Sales Agreement with Ascendiant Capital Markets for up to $6.5M of common stock.
- Shares sold from time to time at market prices; agent receives customary commission.
- Prospectus supplement filed Oct 3, 2024; relies on shelf registration statement 333-273610.
- ATM offering provides additional capital but dilutes existing shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924017141/0001214659-24-017141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924017141/g1032408k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-24-017141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer